A newly described vancomycin-resistant ST412 Enterococcus faecium predominant in Greek hospitals

A Damani; D Klapsa; M Panopoulou; I Spiliopoulou; K Pantelidi; E Malli; F Kolonitsiou; S Grapsa; E Alepopoulou; F Frantzidou; E Vlahaki; C Koutsia-Carouzou; H Malamou-Lada; L Zerva; S Kartali-Ktenidou; E D Anastassiou; A N Maniatis; E Petinaki

doi:10.1007/s10096-009-0847-9

A newly described vancomycin-resistant ST412 Enterococcus faecium predominant in Greek hospitals

Eur J Clin Microbiol Infect Dis. 2010 Mar;29(3):329-31. doi: 10.1007/s10096-009-0847-9. Epub 2009 Dec 17.

Authors

A Damani¹, D Klapsa, M Panopoulou, I Spiliopoulou, K Pantelidi, E Malli, F Kolonitsiou, S Grapsa, E Alepopoulou, F Frantzidou, E Vlahaki, C Koutsia-Carouzou, H Malamou-Lada, L Zerva, S Kartali-Ktenidou, E D Anastassiou, A N Maniatis, E Petinaki

Affiliation

¹ Department of Molecular Microbiology, Institute of Biomedical Research and Technology, Larissa, Greece.

PMID: 20016994
DOI: 10.1007/s10096-009-0847-9

Abstract

A total of 359 vancomycin-resistant enterococci (344 Enterococcus faecium and 15 E. faecalis) collected during 2007 from eight tertiary-care hospitals in Greece were analysed for genotypic characteristics. Four common clones, ST412, ST203, ST16 and ST17, were identified among E. faecium and one clone, ST28, among E. faecalis strains.

MeSH terms

Anti-Bacterial Agents / pharmacology
Cross Infection / microbiology*
Electrophoresis, Gel, Pulsed-Field
Enterococcus faecalis / drug effects
Enterococcus faecalis / genetics
Enterococcus faecalis / isolation & purification
Enterococcus faecium / drug effects
Enterococcus faecium / genetics*
Enterococcus faecium / isolation & purification
Genes, Bacterial
Gram-Positive Bacterial Infections / microbiology*
Greece
Hospitals
Humans
Microbial Sensitivity Tests
Sequence Analysis, DNA
Vancomycin Resistance / genetics*

Substances

Anti-Bacterial Agents